Common genetic variants and risk for HPV persistence and progression to cervical cancer. - Wikidata - thesis-toulmin - TriplyDB

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

http://www.wikidata.org/entity/Q33525051

about

The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients Replicative DNA polymerase mutations in cancer Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases DNA replication fidelity and cancer Clinical implications of interferon-γ genetic and epigenetic variants Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials Genetic admixture and population substructure in Guanacaste Costa Rica Development of a PCR assay to detect papillomavirus infection in the snow leopard.High incidence of oncogenic HPV genotypes found in women from Southern Brazil.Polymorphisms in immune mediators associate with risk of cervical cancer Genetic association between the HIF-1α P582S polymorphism and cervical cancer risk: a meta analysis.RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian Women Common genetic variants related to genomic integrity and risk of papillary thyroid cancer Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk Gamma interferon controls mouse polyomavirus infection in vivo Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk.Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.Chromosomal radiosensitivity of human immunodeficiency virus positive/negative cervical cancer patients in South Africa.A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.Genetic susceptibility of cervical cancer.Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.Nuclear import sequence identification in hOAS3 protein.Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.Transmembrane channel-like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma.Role of inflammasome genetics in susceptibility to HPV infection and cervical cancer development.Long-term follow-up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV-negative women after conization.Improved genetic association tests for an ordinal outcome representing the disease progression process.Women whose cervical intraepithelial neoplasia has been treated or resolved remain at continued high risk for cervical cancer.Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer.

P2860

Q26747402-FF44E6AD-597B-4EA6-8172-E91AC8DEB697 Q26825747-0E7C2B44-9B1B-4EEC-AE47-9C5F2134189B Q28082381-67565B76-87CD-447A-89D9-B7DEA786D49E Q28295863-794F36E5-D905-49BE-A9E6-12B0B2D3D465 Q28383437-B8176297-70C2-4332-9E03-57B80ED38DB3 Q28730698-AB6FE79D-26D9-4E96-A09C-02B6032475B5 Q30557445-301189BA-178B-42BA-A5DE-CEBFAFC9C75E Q31036080-9E45B2DD-DE66-464F-B20A-5CAAC2177FE8 Q33725471-031EC785-BB32-4DC1-91FB-CA8FB22C3754 Q33964484-626F02A1-7B63-48EF-AA79-BC090D025430 Q34198435-71B9603D-A865-4B5E-BE3A-567BD5733406 Q34345226-6C4D022F-1541-4858-B621-20C8BC9E227C Q34371586-C2AC53BC-2131-4D9A-9CED-E237F382542C Q34796264-F1058B7E-1A6C-4AA9-B2ED-899CC4B5E62B Q35193949-3F093F84-BF24-4124-BB1F-37E425AFDD4D Q35203306-71BC4991-7364-46DF-8BCD-DB2ADBF019F2 Q35325994-3342A41B-E4B1-4D34-912A-2B7A2CF06EE2 Q35382791-37500B93-79E8-44AF-94DB-A264DF68CE44 Q35731430-0EAFFAF2-62A2-418F-BF09-4100CD3B2862 Q35788495-E8DBCF97-4775-4DC9-A6C1-474DA7A6FC57 Q35903837-78A43676-D090-4E2B-8EF8-782BE65F8697 Q36070191-F7F0FE9D-6116-408D-B8F8-C8FFEE701007 Q36207032-BC88DF73-5E92-432A-B24A-CB09042B2824 Q36390334-210BB0BB-75A8-4133-83DE-CF6737EDE821 Q36446984-8D081334-62AB-461A-939A-AFD3C4BB472E Q36489770-C5073ED1-87F0-4E61-9C9A-6F7526289B1A Q36683202-3AE416F8-F29F-4695-BE0F-151DEECF5DF4 Q37227774-B699121D-E1E8-4A05-B1CF-DB5DE92565EF Q37347357-B353C917-1024-43A9-8E01-D9C5C256EDC6 Q37350822-F7A0E558-0533-4870-AD42-8ACDF3902A45 Q37661158-899A8675-9ED2-4042-96CC-A33ABBD6CEFD Q38642781-8F41CAC2-C8F4-42F9-8C55-CFD019343E6F Q38759799-CBCFC975-6832-408B-96E2-568340C1D9AA Q39836449-F85C749D-516B-449B-A785-84C224819191 Q40092824-2F33D435-7A29-4212-B4A0-E70B4C5346CD Q40766665-18728D28-BA77-4156-AF58-0A19A4C2B129 Q40771931-87913BD0-FE51-4954-BC38-2AACD8EF5E18 Q43995748-A8DD33E5-61C2-4D8A-B0CA-D44D0BB37813 Q44501482-8418B3CD-EB1A-4175-A406-351324CD78F4 Q44678344-D79DFD38-60F4-4180-A642-6E357398B7DD

P2860

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

http://www.wikidata.org/entity/Q33525051

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@ast

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@en

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@nl

type

label

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@ast

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@en

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@nl

prefLabel

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@ast

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@en

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@nl

P1433

Q33525051-56FBBD94-98A6-42A1-B75C-A366A51675CD

P1476

Q33525051-CC6096C2-2ADF-43D0-8BBA-E40D1108D6D9

P2093

Q33525051-5E6B082D-BF33-47BC-8F98-A9E63EC78219

Q33525051-625B2EEC-C1C5-4C5F-99A5-7852B2B4910A

Q33525051-81A4736C-A433-4157-ADF1-D7E6A4F08B33

Q33525051-8761643A-99EF-4B12-84F1-4FE87C5F729B

Q33525051-9DA08563-8170-4BF9-83DA-FB765BDD3A52

Q33525051-A1B04EEB-E0A5-43E6-9175-E9089CA6216B

Q33525051-AF8B36C7-11D5-48F7-9996-3D7880EB285E

Q33525051-B489704C-6244-4C94-8ACB-B567D1A838D5

Q33525051-D5FDFED2-4B37-4A58-B9F1-638FB5BAD35E

P2860

Q33525051-10BE34C7-B5B8-4E11-8E73-2317FDABC3BB

Q33525051-2482FB23-2CB3-40DB-997E-540BBD54C46B

Q33525051-36CDA55A-59C6-4162-B654-3D9633869C3A

Q33525051-4CD9D71F-4884-4EE1-8DF6-95EC53DEA967

Q33525051-57DAA272-202D-4026-94AC-F99FB1327447

Q33525051-5F57109D-C25B-4BA4-A2BC-4DA0F4F5B874

Q33525051-63B326C4-362C-4D5C-843A-C8BB89D67091

Q33525051-78E54D5B-BE4A-4AF0-8C28-3916B6EC28EC

Q33525051-90D23159-B93A-4682-A921-FE3F281A9A03

Q33525051-CE74792C-B9DB-4590-9374-251F09E9B5F8

P304

Q33525051-C82C1695-0823-44E2-BB76-C8EB54B66BAF

P31

Q33525051-5FAFEC00-3ACA-4FE6-A504-4869AECC868A

P356

Q33525051-04A75DDA-84F5-421D-94F4-BF8FD46309B3

P407

Q33525051-022D036A-C875-487F-9858-97FF329E0C9D

P433

Q33525051-02C7B0AE-9387-4F18-B4E1-7A8FB5392551

P478

Q33525051-3C92C665-AF1E-4425-BF7A-0DB29B4D15E1

P50

Q33525051-0C034D7E-C405-4A83-B630-A8EBF67B2807

Q33525051-13324C70-FC51-4DFE-AD19-40888529FF5F

Q33525051-6EFA4B44-D291-4F85-83BB-B32AC4FB994E

Q33525051-943F9AFD-F544-4814-95E6-2E1E20385FBD

Q33525051-9DEFC164-07A1-49C4-BC93-29D9B807B916

Q33525051-C6645E34-AB73-4DD7-8BE2-AFD1D6BD3D8F

P577

Q33525051-35106BBE-06AE-4361-A14C-16D5584A608C

P5875

Q33525051-AE37D7F7-84E8-47BC-BFC0-996A6CD70FDA

P698

Q33525051-A3F97287-2D6D-47F4-8542-8B69D035B9BF

P932

Q33525051-EF0F6775-DE59-4FCD-9CA3-B8A3E2D976A3

P356

JOURNAL.PONE.0008667

P1433

P1476

Common genetic variants and risk for HPV persistence and progression to cervical cancer.

@en

P2093

Carolina Porras

http://www.w3.org/2001/XMLSchema#string

Concepcion Bratti

http://www.w3.org/2001/XMLSchema#string

Kai Yu

http://www.w3.org/2001/XMLSchema#string

Mark E Sherman

http://www.w3.org/2001/XMLSchema#string

Paula Gonzalez

http://www.w3.org/2001/XMLSchema#string

Qizhai Li

http://www.w3.org/2001/XMLSchema#string

Robert D Burk

http://www.w3.org/2001/XMLSchema#string

Rolando Herrero

http://www.w3.org/2001/XMLSchema#string

Sophia S Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus

Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

Haploview: analysis and visualization of LD and haplotype maps

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

Human DNA repair genes, 2005.

Host and viral genetics and risk of cervical cancer: a review.

Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer

P304

e8667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0008667

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Chanock

Sholom Wacholder

Allan Hildesheim

Ana Cecilia Rodríguez

Mahboobeh Safaeian

P577

2010-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41056854

http://www.w3.org/2001/XMLSchema#string

P698

20084279

http://www.w3.org/2001/XMLSchema#string

P932

2801608

http://www.w3.org/2001/XMLSchema#string